CORRECTED: Caliper Looks to Grow Business by Making Chips Smaller and Cheaper | GenomeWeb

This story has been corrected from a previous version that ran on March 22, which cited an anlyst as saying that the Agilent 2100 sold for $100,000. The company said the correct price is approximately $20,000.

NEW YORK, March 22 – Caliper Technologies of Mountain View, Calif., wants to sell microfluidics chips the way Gillette sells razor blades.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.